Dr. William Stern, Ph.D., serves as President of the Company. He was President, Vice Chairman of the Board of the Company. He was Chief Executive Officer and Director of Nanovibronix, Inc. Previously, he served as an Independent Director - Nominee of the Company. Dr. Stern has served as president of Multigon Industries, Inc., which manufactures non-invasive ultrasound technology that measures blood flow in the brain, since 1984. From 2000 to the present, Dr. Stern has also served as the vice president of Aqua-Eez, Inc., an affiliate of Multigon Industries, Inc. that manufactures and sells a hydrotherapy pool for labor and delivery. From 1972 to 1983, he was the president of Unigon Industries, Inc., which manufactured and distributed diagnostic ultrasound for vascular and neurological diagnostics. Dr. Stern received his Ph.D. in engineering and physics from Columbia University and holds an M.S. and a B.S. degree in electrical engineering from Columbia University and City College of New York, respectively. Dr. Stern’s qualifications to serve on our board include his significant scientific background and over 30 years of executive leadership experience in the field of medical devices and ultrasound technology.
William Stern is 72, he's been the President of NanoVibronix Inc since 2017. There are no older and 9 younger executives at NanoVibronix Inc.
William's mailing address filed with the SEC is C/O NANOVIBRONIX, INC., 525 EXECUTIVE BOULEVARD, ELMSFORD, NY, 10523.
Over the last 8 years, insiders at NanoVibronix Inc have traded over $0 worth of NanoVibronix Inc stock and bought 131,000 units worth $98,060 . The most active insiders traders include Christopher M Fashek, Thomas Mika, and Harold Jacob. On average, NanoVibronix Inc executives and independent directors trade stock every 190 days with the average trade being worth of $14,078. The most recent stock trade was executed by Thomas Mika on 5 January 2023, trading 50,000 units of NAOV stock currently worth $12,500.
nanovibronix inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. the company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. this unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. the company's patch based product diagnosis, painshield®, carries an fda clearance. nanovibronix catheter based products include the cathbottm . nanovibronix inc. is located in elmsford, ny. its subsidiary, nanovibronix ltd. is located in nesher, israel.
NanoVibronix Inc executives and other stock owners filed with the SEC include: